These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3251666)

  • 1. Restoration of normal thyrotrophin secretion reduces the abnormally high serum glutathione S-transferase levels found in patients receiving thyroxine replacement therapy.
    Gow SM; Caldwell G; Toft AD; Sweeting VM; Beckett GJ
    Clin Endocrinol (Oxf); 1988 Sep; 29(3):249-56. PubMed ID: 3251666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement.
    Gow SM; Caldwell G; Toft AD; Seth J; Hussey AJ; Sweeting VM; Beckett GJ
    J Clin Endocrinol Metab; 1987 Feb; 64(2):364-70. PubMed ID: 3793854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
    Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
    J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with thyroxine on pituitary TSH secretion and heart action in patients with hypothyroidism.
    Yamauchi K; Takasu N; Ichikawa K; Yamada T; Aizawa T
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):218-24. PubMed ID: 6495989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
    Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism.
    Price DE; O'Malley BP; Northover B; Rosenthal FD
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):67-9. PubMed ID: 1889141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
    Kabadi UM; Cech R
    J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
    Frey HM; Haug E
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment.
    Carr D; McLeod DT; Parry G; Thornes HM
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):325-33. PubMed ID: 3139338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic markers in blood reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Exp Clin Endocrinol; 1992; 99(3):129-33. PubMed ID: 1526260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Acta Med Hung; 1991; 48(1-2):33-43. PubMed ID: 1813856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotrophin.
    Yoshinari M; Tokuyama T; Kuroda T; Sato K; Okazawa K; Mizokami T; Okamura K; Fujishima M
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):355-60. PubMed ID: 1424168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate replacement dose of thyroxine in primary hypothyroidism.
    Frey H; Johannesen O; Kapelrud H; Sand T
    Acta Med Scand; 1987; 222(2):163-7. PubMed ID: 3673668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different hepatic responses to thyroxine replacement in spontaneous and 131I-induced primary hypothyroidism.
    Gow SM; Caldwell G; Toft AD; Beckett GJ
    Clin Endocrinol (Oxf); 1989 May; 30(5):505-12. PubMed ID: 2605787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients.
    Soppi E; Irjala K; Kaihola HL; Viikari J
    Scand J Clin Lab Invest; 1984 Jun; 44(4):353-6. PubMed ID: 6463564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal thyrotrophin response to intravenous thyrotrophin releasing hormone administration: the best index of optimal L-thyroxine therapy in primary hypothyroidism.
    Kabadi UM
    Postgrad Med J; 1985 Aug; 61(718):685-8. PubMed ID: 3929241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of primary hypothyroidism with L-triiodothyronine: discordant cardiac and pituitary responses.
    Ridgway EC; Cooper DS; Walker H; Daniels GH; Chin WW; Myers G; Maloof F
    Clin Endocrinol (Oxf); 1980 Nov; 13(5):479-88. PubMed ID: 7226568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.